AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
7680693100015
CH-69310
Pulver
Associated product:
AREXVY subst sèche c solv flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
120.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
12C
|
120.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
1.78 MG | Substance | HBESI |
|
12C
|
0.35 MG | Substance | HBESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 69310
- Drug name
- AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07BX05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 02/05/2024
- Authorization expiration date
- 01/05/2029
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- AREXVY subst sèche c solv flac
- Description (DE)
- AREXVY Trockensub c Solv Durchstf
- Market launch
- 02/05/2024
- Narcotic (BTM)
- No